(Q45124890)

English

Development of a quantitative assay for residual host cell proteins in a recombinant subunit vaccine against human respiratory syncytial virus

scientific article published in May 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Development of a quantitative assay for residual host cell proteins in a recombinant subunit vaccine against human respiratory syncytial virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

respiratory syncytial virus

object named as

human respiratory syncytial virus

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Dagouassat N

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Haeuw JF

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Robillard V

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Damien F

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Libon C

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Corvaïa N

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Lawny F

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Nguyen TN

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Bonnefoy JY

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Beck A

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

251

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

151-159

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Preliminary studies on the immunogenicity and amount of Escherichia coli polypeptides in biosynthetic human insulin produced by recombinant DNA technology

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridges

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Quantitation of DNA and protein impurities in biopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Quantitation of E. coli protein impurities in recombinant human interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Host cell contaminant protein assay development for recombinant biopharmaceuticals.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Use of a light-addressable potentiometric sensor for the detection of Escherichia coli O157:H7

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Light-Addressable Potentiometric Sensor for Biochemical Systems

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Identification of an Escherichia coli protein impurity in preparations of a recombinant pharmaceutical

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

A silicon sensor-based filtration immunoassay using biotin-mediated capture

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Cascade immunization: a method of obtaining polyspecific antisera against crude fractions of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

An immunoligand assay for quantitation of process specific Escherichia coli host cell contaminant proteins in a recombinant bovine somatotropin.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900321-0

7 January 2021

Identifiers

10.1016/S0022-1759(01)00321-0

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45124890&oldid=2095130336"